NCT07370584
A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 29 words Show 4 more changesShow less
- Trial completed
- Primary completion date changed from estimate of May 2026 to Apr 1, 2026
- Study completion date changed from estimate of Jul 2026 to May 13, 2026
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Jan 2026 to Feb 4, 2026
- Minor Study title shortened, about 5 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Visual acuity
Timeframe: From enrollment to the end of treatment at 6 weeks
Change in eye assessments
Timeframe: From enrollment to the end of treatment at 6 weeks
Punctal stenosis or Bloody discharge
Timeframe: From enrollment to the end of treatment at 6 weeks
Change in ocular assessments
Timeframe: From enrollment to the end of treatment at 6 weeks
Arms and interventions
Vehicle ophthalmic solutionPlacebo comparator
Vehicle ophthalmic solution, administered twice a day
IVMED-85 ophthalmic solutionExperimental
IVMED-85 ophthalmic solution (0.20 mg/mL)
Drugs: IVMED-85 ophthalmic solution, Vehicle Ophthalmic Solution
Sites
1 site in 1 country
- Total Eye Care, P.A.Memphis, Tennessee, United States